» Articles » PMID: 37063873

Functional Plasticity of Neutrophils After Low- or High-dose Irradiation in Cancer Treatment - A Mini Review

Overview
Journal Front Immunol
Date 2023 Apr 17
PMID 37063873
Authors
Affiliations
Soon will be listed here.
Abstract

Over the last several decades, radiotherapy has been considered the primary treatment option for a broad range of cancer types, aimed at prolonging patients' survival and slowing down tumor regression. However, therapeutic outcomes of radiotherapy remain limited, and patients suffer from relapse shortly after radiation. Neutrophils can initiate an immune response to infection by releasing cytokines and chemokines to actively combat pathogens. In tumor immune microenvironment, tumor-derived signals reprogram neutrophils and induce their heterogeneity and functional versatility to promote or inhibit tumor growth. In this review, we present an overview of the typical phenotypes of neutrophils that emerge after exposure to low- and high-dose radiation. These phenotypes hold potential for developing synergistic therapeutic strategies to inhibit immunosuppressive activity and improve the antitumor effects of neutrophils to render radiation therapy as a more effective strategy for cancer patients, through tumor microenvironment modulation.

Citing Articles

β-Lapachone promotes the recruitment and polarization of tumor-associated neutrophils (TANs) toward an antitumor (N1) phenotype in NQO1-positive cancers.

Tumbath S, Jiang L, Li X, Zhang T, Zahid K, Zhao Y Oncoimmunology. 2024; 13(1):2363000.

PMID: 38846085 PMC: 11155710. DOI: 10.1080/2162402X.2024.2363000.


Chemotherapy-induced toxic epidermal necrolysis in a patient with multiple myeloma, a case report and literature review.

X R, W M, W G, Z L, W X, C W Front Oncol. 2023; 13:1227448.

PMID: 37601673 PMC: 10433741. DOI: 10.3389/fonc.2023.1227448.

References
1.
Xiong S, Dong L, Cheng L . Neutrophils in cancer carcinogenesis and metastasis. J Hematol Oncol. 2021; 14(1):173. PMC: 8529570. DOI: 10.1186/s13045-021-01187-y. View

2.
Sagiv J, Michaeli J, Assi S, Mishalian I, Kisos H, Levy L . Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep. 2015; 10(4):562-73. DOI: 10.1016/j.celrep.2014.12.039. View

3.
Liang H, Deng L, Hou Y, Meng X, Huang X, Rao E . Host STING-dependent MDSC mobilization drives extrinsic radiation resistance. Nat Commun. 2017; 8(1):1736. PMC: 5701019. DOI: 10.1038/s41467-017-01566-5. View

4.
Tesmer L, Lundy S, Sarkar S, Fox D . Th17 cells in human disease. Immunol Rev. 2008; 223:87-113. PMC: 3299089. DOI: 10.1111/j.1600-065X.2008.00628.x. View

5.
Patel R, Hernandez R, Carlson P, Grudzinski J, Bates A, Jagodinsky J . Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade. Sci Transl Med. 2021; 13(602). PMC: 8449934. DOI: 10.1126/scitranslmed.abb3631. View